论文部分内容阅读
目的:评价消炎利胆片对急性胆囊炎患者微创术后利胆的疗效。方法:选取2014年4月—2015年4月间收治的急性胆囊炎患者76例,采用随机数字法将其分为对照组和观察组(每组38例);对照组患者给予腹腔镜手术治疗,观察组患者在对照组治疗的基础上加用消炎利胆片治疗,比较两组患者治疗后的总有效率、出血量和肛门排气时间、住院时间以及不良反应的发生率。结果:观察组患者治疗后的总有效率为92.11%高于对照组为71.05%(P<0.05),出血量和肛门排气时间、住院时间优于对照组(P<0.05),不良反应的发生率低于对照组(P<0.05)。结论:采用消炎利胆片治疗急性胆囊炎患者微创术后消炎利胆的疗效较为明显,其出血量少,术后肛门排气时间早,住院时间短以及不良反应的发生率较低。
Objective: To evaluate the efficacy of Xiaoyanlidan tablet in patients with acute cholecystitis after minimally invasive surgery. Methods: A total of 76 patients with acute cholecystitis admitted from April 2014 to April 2015 were selected and divided into control group and observation group (38 cases in each group) by random number method. Patients in control group were given laparoscopic surgery The patients in the observation group were treated with Xiaoyanlidan tablet on the basis of the control group. The total effective rate, the amount of bleeding, the time of anal exhaust, the length of hospital stay and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate of the observation group after treatment was 92.11%, which was significantly higher than that of the control group (71.05%, P <0.05). The bleeding volume, anal exhaust time and hospital stay were better than those of the control group (P <0.05) The incidence was lower than that of the control group (P <0.05). Conclusion: The anti-inflammatory and cholecystitis treated with Xiaoyanlidan tablet in patients with acute cholecystitis has more obvious curative effect. It has less bleeding, early postoperative anal exhaust, shorter hospital stay and lower incidence of adverse reactions.